BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 16702386)

  • 1. Common genetic variation at PTEN and risk of sporadic breast and prostate cancer.
    Haiman CA; Stram DO; Cheng I; Giorgi EE; Pooler L; Penney K; Le Marchand L; Henderson BE; Freedman ML
    Cancer Epidemiol Biomarkers Prev; 2006 May; 15(5):1021-5. PubMed ID: 16702386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A haplotype-based case-control study of BRCA1 and sporadic breast cancer risk.
    Freedman ML; Penney KL; Stram DO; Riley S; McKean-Cowdin R; Le Marchand L; Altshuler D; Haiman CA
    Cancer Res; 2005 Aug; 65(16):7516-22. PubMed ID: 16103107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comprehensive haplotype analysis of CYP19 and breast cancer risk: the Multiethnic Cohort.
    Haiman CA; Stram DO; Pike MC; Kolonel LN; Burtt NP; Altshuler D; Hirschhorn J; Henderson BE
    Hum Mol Genet; 2003 Oct; 12(20):2679-92. PubMed ID: 12944421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A systematic assessment of common genetic variation in CYP11A and risk of breast cancer.
    Setiawan VW; Cheng I; Stram DO; Giorgi E; Pike MC; Van Den Berg D; Pooler L; Burtt NP; Le Marchand L; Altshuler D; Hirschhorn J; Henderson BE; Haiman CA
    Cancer Res; 2006 Dec; 66(24):12019-25. PubMed ID: 17178901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Common variation in BRCA2 and breast cancer risk: a haplotype-based analysis in the Multiethnic Cohort.
    Freedman ML; Penney KL; Stram DO; Le Marchand L; Hirschhorn JN; Kolonel LN; Altshuler D; Henderson BE; Haiman CA
    Hum Mol Genet; 2004 Oct; 13(20):2431-41. PubMed ID: 15317758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A haplotype analysis of HER-2 gene polymorphisms: association with breast cancer risk, HER-2 protein expression in the tumor, and disease recurrence in Korea.
    Han W; Kang D; Lee JE; Park IA; Choi JY; Lee KM; Bae JY; Kim S; Shin ES; Lee JE; Shin HJ; Kim SW; Kim SW; Noh DY
    Clin Cancer Res; 2005 Jul; 11(13):4775-8. PubMed ID: 16000574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequence variants in Toll-like receptor gene cluster (TLR6-TLR1-TLR10) and prostate cancer risk.
    Sun J; Wiklund F; Zheng SL; Chang B; Bälter K; Li L; Johansson JE; Li G; Adami HO; Liu W; Tolin A; Turner AR; Meyers DA; Isaacs WB; Xu J; Grönberg H
    J Natl Cancer Inst; 2005 Apr; 97(7):525-32. PubMed ID: 15812078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comprehensive analysis of the androgen receptor gene and risk of breast cancer: results from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium (BPC3).
    Cox DG; Blanché H; Pearce CL; Calle EE; Colditz GA; Pike MC; Albanes D; Allen NE; Amiano P; Berglund G; Boeing H; Buring J; Burtt N; Canzian F; Chanock S; Clavel-Chapelon F; Feigelson HS; Freedman M; Haiman CA; Hankinson SE; Henderson BE; Hoover R; Hunter DJ; Kaaks R; Kolonel L; Kraft P; LeMarchand L; Lund E; Palli D; Peeters PH; Riboli E; Stram DO; Thun M; Tjonneland A; Trichopoulos D; Yeager M;
    Breast Cancer Res; 2006; 8(5):R54. PubMed ID: 16987421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clarifying the PROGINS allele association in ovarian and breast cancer risk: a haplotype-based analysis.
    Pearce CL; Hirschhorn JN; Wu AH; Burtt NP; Stram DO; Young S; Kolonel LN; Henderson BE; Altshuler D; Pike MC
    J Natl Cancer Inst; 2005 Jan; 97(1):51-9. PubMed ID: 15632380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sequence variants of Toll-like receptor 4 and susceptibility to prostate cancer.
    Chen YC; Giovannucci E; Lazarus R; Kraft P; Ketkar S; Hunter DJ
    Cancer Res; 2005 Dec; 65(24):11771-8. PubMed ID: 16357190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogen receptor beta polymorphism is associated with prostate cancer risk.
    Thellenberg-Karlsson C; Lindström S; Malmer B; Wiklund F; Augustsson-Bälter K; Adami HO; Stattin P; Nilsson M; Dahlman-Wright K; Gustafsson JA; Grönberg H
    Clin Cancer Res; 2006 Mar; 12(6):1936-41. PubMed ID: 16551880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutation analysis and characterization of ATR sequence variants in breast cancer cases from high-risk French Canadian breast/ovarian cancer families.
    Durocher F; Labrie Y; Soucy P; Sinilnikova O; Labuda D; Bessette P; Chiquette J; Laframboise R; Lépine J; Lespérance B; Ouellette G; Pichette R; Plante M; Tavtigian SV; Simard J
    BMC Cancer; 2006 Sep; 6():230. PubMed ID: 17010193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T29C polymorphism in the transforming growth factor beta1 gene and postmenopausal breast cancer risk: the Multiethnic Cohort Study.
    Le Marchand L; Haiman CA; van den Berg D; Wilkens LR; Kolonel LN; Henderson BE
    Cancer Epidemiol Biomarkers Prev; 2004 Mar; 13(3):412-5. PubMed ID: 15006917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between Toll-like receptor gene cluster (TLR6, TLR1, and TLR10) and prostate cancer.
    Chen YC; Giovannucci E; Kraft P; Lazarus R; Hunter DJ
    Cancer Epidemiol Biomarkers Prev; 2007 Oct; 16(10):1982-9. PubMed ID: 17932345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitamin D receptor polymorphisms and breast cancer risk: results from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium.
    McKay JD; McCullough ML; Ziegler RG; Kraft P; Saltzman BS; Riboli E; Barricarte A; Berg CD; Bergland G; Bingham S; Brustad M; Bueno-de-Mesquita HB; Burdette L; Buring J; Calle EE; Chanock SJ; Clavel-Chapelon F; Cox DG; Dossus L; Feigelson HS; Haiman CA; Hankinson SE; Hoover RN; Hunter DJ; Husing A; Kaaks R; Kolonel LN; Le Marchand L; Linseisen J; McCarty CA; Overvad K; Panico S; Purdue MP; Stram DO; Stevens VL; Trichopoulos D; Willett WC; Yuenger J; Thun MJ
    Cancer Epidemiol Biomarkers Prev; 2009 Jan; 18(1):297-305. PubMed ID: 19124512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogen receptor genotypes and haplotypes associated with breast cancer risk.
    Gold B; Kalush F; Bergeron J; Scott K; Mitra N; Wilson K; Ellis N; Huang H; Chen M; Lippert R; Halldorsson BV; Woodworth B; White T; Clark AG; Parl FF; Broder S; Dean M; Offit K
    Cancer Res; 2004 Dec; 64(24):8891-900. PubMed ID: 15604249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Haplotype-based association studies of IGFBP1 and IGFBP3 with prostate and breast cancer risk: the multiethnic cohort.
    Cheng I; Penney KL; Stram DO; Le Marchand L; Giorgi E; Haiman CA; Kolonel LN; Pike M; Hirschhorn J; Henderson BE; Freedman ML
    Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1993-7. PubMed ID: 17035411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A genome-wide association screen identifies regions on chromosomes 1q25 and 7p21 as risk loci for sporadic prostate cancer.
    Nam RK; Zhang WW; Loblaw DA; Klotz LH; Trachtenberg J; Jewett MA; Stanimirovic A; Davies TO; Toi A; Venkateswaran V; Sugar L; Siminovitch KA; Narod SA
    Prostate Cancer Prostatic Dis; 2008; 11(3):241-6. PubMed ID: 17876339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive survey of common genetic variation at the plasminogen activator inhibitor-1 locus and relations to circulating plasminogen activator inhibitor-1 levels.
    Kathiresan S; Gabriel SB; Yang Q; Lochner AL; Larson MG; Levy D; Tofler GH; Hirschhorn JN; O'Donnell CJ
    Circulation; 2005 Sep; 112(12):1728-35. PubMed ID: 16172282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COX-2 gene promoter haplotypes and prostate cancer risk.
    Panguluri RC; Long LO; Chen W; Wang S; Coulibaly A; Ukoli F; Jackson A; Weinrich S; Ahaghotu C; Isaacs W; Kittles RA
    Carcinogenesis; 2004 Jun; 25(6):961-6. PubMed ID: 14754878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.